Low and Intermediate Risk Prostate Cancer
Clinical trials for patients who are diagnosed with low to intermediate risk prostate cancer (Gleason 6 or 7). Patients may be interested in active surveillance or making a decision to begin active treatment. This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.
Prostate Cancer Clinical Trials page coming soon.